Delivery Order SPE2DB22D1017-SPE2DB25FE7RZ
Award Date
10/22/24
Potential Completion Date
10/23/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,253.69 firm fixed-price delivery order contract has a completion date of February 25, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The federal contract award is for the delivery of the pharmaceutical product DUPIXENT 200 MG/1.14 ML PEN 1.14ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $5,633.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a completion date of June 11, 2025. The award is not a set-aside contract, indicating open competition. Amerisourcebergen...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $24,578.72 firm fixed-price delivery order has a period of performance through March 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $79,621.50 and a completion date of June 4, 2024. The award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,661.72, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical and medical products to the U.S. federal government. The contract is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,657.18 delivery order contract has a February 2025 completion date and is issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,034.90 firm fixed price delivery order is issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $13,336.96. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is January 11, 2024. This contract award is not...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, procured by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,111.80 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024 with a completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award is for the pharmaceutical product DUPIXENT 200 MG/1.14 ML PEN 1.14ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,598.90 and an ultimate completion date of August 21, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...